Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation
Cancer Science · 2025
DOI: 10.1111/cas.16417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Yuankun Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical and Liver Diseases, The Second Affiliated Hospital of Hainan Medical University, Haikou, China. Hauptthemen laut MEDLINE: Exosomes, Liver Neoplasms, Cancer-Associated Fibroblasts, Lung Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hainan Provincial Natural Science Foundation of China, Recognition of the 'Suzhou Municipal Health Young Backbone Talents' National Mentorship Training Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer‐associated fibroblasts (CAFs) are essential players in the tumor microenvironment (TME) due to their roles in facilitating tumor progression and metastasis. It is worth noting that the high‐metastatic hepatocellular carcinoma (HCC) cell‐derived exosomes have exhibited the ability to transform normal fibroblasts into CAFs, which further fosters the lung metastasis of low‐metastatic HCC cells. Yet, the mechanisms underlying this tumor exosome‐induced metastatic niche formation are poorly explored. In this study, the secreted protein arginyl aminopeptidase (RNPEP) was highly expressed in the plasma of patients with HCC. In addition, high‐metastatic HCC cells showed augmented RNPEP expression levels in their exosomes. These exosomes induced obvious CAF‐like properties in the human fibroblast cell line MRC‐5, as evidenced by the increased CAF marker expression, and enhanced migratory ability. More strikingly, the secretions from high‐metastatic tumor exosome‐educated MRC‐5 cells increased tumor stemness and promoted epithelial–mesenchymal transition (EMT) in MHCC‐97L cells, a low‐metastatic HCC cell line. However, the knockdown of RNPEP in exosomes from high‐metastatic HCC cells abated the changes described above. Animal studies in vivo highlighted the pro‐tumor and pro‐metastatic effects of exosomal RNPEP on MHCC‐97L cells by inducing CAF activation. Furthermore, tumor‐derived exosomal RNPEP induced the activation of NF‐κB signaling in MRC‐5 cells, a critical pathway associated with CAF activation. Collectively, these results provide novel insight into tumor‐derived exosomal RNPEP for its crosstalk with CAFs during HCC lung metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tropical and Liver Diseases, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
- Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
- Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Infectious Diseases, The First People's Hospital of Kunshan, Kunshan, China.
ORCID-Profile: Wenting Li
Förderung
- Hainan Provincial Natural Science Foundation of China
- Recognition of the 'Suzhou Municipal Health Young Backbone Talents' National Mentorship Training Program
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Pan, G., Yang, Y., Wu, H., Weng, M., Wu, Q., Gao, Y., & Li, W. (2025). Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation. Cancer Science. https://doi.org/10.1111/cas.16417
Vancouver
Chen Y, Pan G, Yang Y, Wu H, Weng M, Wu Q, et al. Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation. Cancer Science. 2025. doi:10.1111/cas.16417
BibTeX
@article{Chen2025,
author = {Chen, Yuankun and Pan, Gaofeng and Yang, Yijun and Wu, Haifeng and Weng, Minhua and Wu, Qiuping and Gao, Yufeng and Li, Wenting},
title = {Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16417}
}
EUVIMED